Literature DB >> 10446511

[Epidemiology of dengue and hemorrhagic dengue in Santiago, Cuba 1997].

L Valdés1, M G Guzmán, G Kourí, J Delgado, I Carbonell, M V Cabrera, D Rosario, S Vázquez.   

Abstract

A dengue epidemic that Cuba reported in 1997 registered more than 500,000 cases of dengue fever produced by viral serotype 1. In 1981, there was an epidemic of dengue hemorrhagic fever produced by serotype 2 of the virus. This time 344,203 clinical cases were reported, 10,312 of which were severe cases of hemorrhagic fever that led to 158 fatalities (101 of them among children). The reintroduction of dengue, and specifically of dengue viral serotype 2 (Jamaica genotype), was quickly detected in January 1997 through an active surveillance system with laboratory confirmation of cases in the municipality of Santiago de Cuba, in the province of the same name. The main epidemiological features of this outbreak are reported in this paper. A total of 3,012 cases were reported and serologically confirmed. These included 205 cases classified as dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), 12 of which were case fatalities (all among adults). Secondary infection with dengue virus was one of the most important risk factors for DHF/DSS. Ninety-eight percent of the DHF/DSS cases and 92% of the fatal cases had contracted a secondary infection. It was the first time dengue hemorrhagic fever was documented as a secondary infection 16 to 20 years after initial infection. Belonging to the white racial group was another important risk factor for DHF/DSS, as had been observed during the 1981 epidemic. During the most recent epidemic it was demonstrated that the so called "fever alert" is not useful for early detection of an epidemic. Measures taken by the country's public health officials prevented spread of the epidemic to other municipalities plagued by Aedes aegypti.

Entities:  

Mesh:

Year:  1999        PMID: 10446511     DOI: 10.1590/s1020-49891999000600003

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  7 in total

1.  The complexity of antibody-dependent enhancement of dengue virus infection.

Authors:  Maria G Guzman; Susana Vazquez
Journal:  Viruses       Date:  2010-12-08       Impact factor: 5.048

Review 2.  Understanding the dengue viruses and progress towards their control.

Authors:  Rosmari Rodriguez-Roche; Ernest A Gould
Journal:  Biomed Res Int       Date:  2013-07-09       Impact factor: 3.411

Review 3.  Dengue viruses - an overview.

Authors:  Anne Tuiskunen Bäck; Ake Lundkvist
Journal:  Infect Ecol Epidemiol       Date:  2013-08-30

4.  Autochthonous Chikungunya Fever in Traveler Returning to Japan from Cuba.

Authors:  Motoyuki Tsuboi; Satoshi Kutsuna; Yasuyuki Kato; Eri Nakayama; Ken-Ichi Shibasaki; Shigeru Tajima; Tomohiko Takasaki; Yuichi Katanami; Kei Yamamoto; Nozomi Takeshita; Kayoko Hayakawa; Shuzo Kanagawa; Norio Ohmagari
Journal:  Emerg Infect Dis       Date:  2016-09       Impact factor: 6.883

5.  Neutralizing antibodies after infection with dengue 1 virus.

Authors:  Maria G Guzman; Mayling Alvarez; Rosmari Rodriguez-Roche; Lidice Bernardo; Tibaire Montes; Susana Vazquez; Luis Morier; Angel Alvarez; Ernest A Gould; Gustavo Kouri; Scott B Halstead
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

6.  Dengue 3 epidemic, Havana, 2001.

Authors:  Otto Peláez; María G Guzmán; Gustavo Kourí; Raúl Pérez; José L San Martín; Susana Vázquez; Delfina Rosario; Regla Mora; Ibrahim Quintana; Juan Bisset; Reynel Cancio; Ana M Masa; Osvaldo Castro; Daniel González; Luis C Avila; Rosmari Rodríguez; Mayling Alvarez; Jose L Pelegrino; Lídice Bernardo; Irina Prado
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

7.  Within-host viral dynamics of dengue serotype 1 infection.

Authors:  Hannah E Clapham; Vianney Tricou; Nguyen Van Vinh Chau; Cameron P Simmons; Neil M Ferguson
Journal:  J R Soc Interface       Date:  2014-07-06       Impact factor: 4.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.